Cucurbitacin D Overcomes Gefitinib Resistance by Blocking EGF Binding to EGFR and Inducing Cell Death in NSCLCs

Frontiers in Oncology
Se Hyang HongSeong-Gyu Ko

Abstract

In this study, the mechanism of the anticancer effect through which cucurbitacin D (CuD) can overcome gefitinib resistance in NSCLC was investigated. Cell viability was measured by 3-(4,5-dimethylthiazol-2-yl)-2-5-diphenyltetrazolium bromide assay, and cell migration and growth were observed by wound healing and colony formation assays, respectively. Levels of EGFR family members, protein kinase B, extracellular signal-regulated kinase, poly(ADP-ribose) polymerase, and G2/M phase-related proteins were detected by Western blot analysis. Immunofluorescence analysis was used to detect the intracellular expression of p-EGFR. Induction of apoptosis and cell cycle arrest was measured by flow cytometry. Solid-phase binding assays were used to determine binding to the EGFR family. CuD inhibits the phosphorylation of EGFR in gefitinib-resistant NSCLC cells and induces cell death via cell cycle arrest and apoptosis. CuD treatment or EGFR knockdown also suppressed the growth of gefitinib-resistant NSCLC cells. In addition, CuD overcame resistance by blocking EGF binding to EGFR in gefitinib-resistant NSCLC cells. In conclusion, we demonstrate that CuD overcomes gefitinib resistance by reducing the activation of EGFR-mediated survival in N...Continue Reading

References

Aug 20, 2002·Ultrastructural Pathology·Zhenhe Suo, Jahn M Nesland
Mar 22, 2003·Experimental Cell Research·Robert N JorissenAntony W Burgess
May 3, 2005·Nature Reviews. Cancer·Nancy E Hynes, Heidi A Lane
Jul 9, 2005·The Journal of Pharmacology and Experimental Therapeutics·Amit Arora, Eric M Scholar
May 15, 2007·Oncogene·A S DhillonW Kolch
Dec 21, 2007·Proceedings of the National Academy of Sciences of the United States of America·James BeanWilliam Pao
Feb 5, 2010·Cancer Cell·Alexa B TurkePasi A Jänne
Oct 23, 2010·Nature Reviews. Cancer·William Pao, Juliann Chmielecki
Nov 26, 2010·Nature Reviews. Molecular Cell Biology·Livio TrusolinoPaolo M Comoglio
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Apr 5, 2011·Bioorganic & Medicinal Chemistry·Judit Bartalis, Fathi T Halaweish
Jun 12, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sanguine ByunZigang Dong
Mar 26, 2014·Cancer Chemotherapy and Pharmacology·Ji Yun LeeMyung-Ju Ahn
Jun 15, 2014·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Robert Roskoski
Apr 30, 2015·Journal of Thoracic Disease·Yang LiZhenxiang Yu
Apr 10, 2016·Molecular Nutrition & Food Research·Rahul K LallHasan Mukhtar
Nov 9, 2016·Scientific Reports·Mohammed SikanderMeena Jaggi
Jan 28, 2017·Nature Reviews. Cancer·Tobias Otto, Piotr Sicinski
Jan 23, 2018·International Journal of Cancer. Journal International Du Cancer·Saki NaritaUNKNOWN JPHC Study Group
Mar 7, 2018·Nature Reviews. Clinical Oncology·Filip JankuFunda Meric-Bernstam
Nov 16, 2018·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Simon BaldacciAlexis B Cortot
Mar 17, 2019·Cancers·Mohammed SikanderSubhash C Chauhan

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
protein assay
X-ray
transfection
flow cytometry

Software Mentioned

ImageJ
Prism
GraphPad

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.